Cargando…

Clarithromycin in Early Pregnancy and the Risk of Miscarriage and Malformation: A Register Based Nationwide Cohort Study

BACKGROUND: The antibiotic clarithromycin has been associated with fetal loss in animals and a study has found a doubling in the frequency of miscarriages among women using clarithromycin in pregnancy. The aim of the study was to investigate whether clarithromycin use in early pregnancy was associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Jon Trærup, Petersen, Morten, Jimenez-Solem, Espen, Broedbaek, Kasper, Andersen, Nadia Lyhne, Torp-Pedersen, Christian, Keiding, Niels, Poulsen, Henrik Enghusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534696/
https://www.ncbi.nlm.nih.gov/pubmed/23301061
http://dx.doi.org/10.1371/journal.pone.0053327
_version_ 1782475385087197184
author Andersen, Jon Trærup
Petersen, Morten
Jimenez-Solem, Espen
Broedbaek, Kasper
Andersen, Nadia Lyhne
Torp-Pedersen, Christian
Keiding, Niels
Poulsen, Henrik Enghusen
author_facet Andersen, Jon Trærup
Petersen, Morten
Jimenez-Solem, Espen
Broedbaek, Kasper
Andersen, Nadia Lyhne
Torp-Pedersen, Christian
Keiding, Niels
Poulsen, Henrik Enghusen
author_sort Andersen, Jon Trærup
collection PubMed
description BACKGROUND: The antibiotic clarithromycin has been associated with fetal loss in animals and a study has found a doubling in the frequency of miscarriages among women using clarithromycin in pregnancy. The aim of the study was to investigate whether clarithromycin use in early pregnancy was associated with an increased risk for miscarriages and major malformations. METHODS: We conducted a nationwide cohort study including all women in Denmark with a known conception between 1997 and 2007. The Fertility Database was used to identify all women giving birth and the National Hospital Register was used to identify all women with a record of miscarriage or induced abortion. Prescription data was obtained from the National Prescription Register. The primary outcome was the number of miscarriages and offspring with major congenital malformations among users of clarithromycin compared to non-users. RESULTS: We identified 931 504 pregnancies (705 837 live births, 77 553 miscarriages, and 148 114 induced abortions). 401 women redeemed a prescription of clarithromycin in the first trimester of which 40 (10.0%) experienced a miscarriage and among the live born nine (3.6%) had offspring with malformations. The hazard ratio (HR) of having a miscarriage after exposure to clarithromycin was 1.56 (CI95% 1.14–2.13). There was no increased hazard of having a miscarriage when being exposed to penicillin or erythromycin. There was no increased prevalence (OR = 1.03 (CI95% 0.52–2.00)) of having offspring with malformations after exposure to clarithromycin. CONCLUSIONS: We found an increased hazard of miscarriage but no increased prevalance of having offspring with malformations among women redeeming a prescription of clarithromycin in early pregnancy. This is supported by previous studies in animals and humans. However, further research is required to explore the possible effect of treatment indication on the associations found.
format Online
Article
Text
id pubmed-3534696
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35346962013-01-08 Clarithromycin in Early Pregnancy and the Risk of Miscarriage and Malformation: A Register Based Nationwide Cohort Study Andersen, Jon Trærup Petersen, Morten Jimenez-Solem, Espen Broedbaek, Kasper Andersen, Nadia Lyhne Torp-Pedersen, Christian Keiding, Niels Poulsen, Henrik Enghusen PLoS One Research Article BACKGROUND: The antibiotic clarithromycin has been associated with fetal loss in animals and a study has found a doubling in the frequency of miscarriages among women using clarithromycin in pregnancy. The aim of the study was to investigate whether clarithromycin use in early pregnancy was associated with an increased risk for miscarriages and major malformations. METHODS: We conducted a nationwide cohort study including all women in Denmark with a known conception between 1997 and 2007. The Fertility Database was used to identify all women giving birth and the National Hospital Register was used to identify all women with a record of miscarriage or induced abortion. Prescription data was obtained from the National Prescription Register. The primary outcome was the number of miscarriages and offspring with major congenital malformations among users of clarithromycin compared to non-users. RESULTS: We identified 931 504 pregnancies (705 837 live births, 77 553 miscarriages, and 148 114 induced abortions). 401 women redeemed a prescription of clarithromycin in the first trimester of which 40 (10.0%) experienced a miscarriage and among the live born nine (3.6%) had offspring with malformations. The hazard ratio (HR) of having a miscarriage after exposure to clarithromycin was 1.56 (CI95% 1.14–2.13). There was no increased hazard of having a miscarriage when being exposed to penicillin or erythromycin. There was no increased prevalence (OR = 1.03 (CI95% 0.52–2.00)) of having offspring with malformations after exposure to clarithromycin. CONCLUSIONS: We found an increased hazard of miscarriage but no increased prevalance of having offspring with malformations among women redeeming a prescription of clarithromycin in early pregnancy. This is supported by previous studies in animals and humans. However, further research is required to explore the possible effect of treatment indication on the associations found. Public Library of Science 2013-01-02 /pmc/articles/PMC3534696/ /pubmed/23301061 http://dx.doi.org/10.1371/journal.pone.0053327 Text en © 2013 Andersen et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Andersen, Jon Trærup
Petersen, Morten
Jimenez-Solem, Espen
Broedbaek, Kasper
Andersen, Nadia Lyhne
Torp-Pedersen, Christian
Keiding, Niels
Poulsen, Henrik Enghusen
Clarithromycin in Early Pregnancy and the Risk of Miscarriage and Malformation: A Register Based Nationwide Cohort Study
title Clarithromycin in Early Pregnancy and the Risk of Miscarriage and Malformation: A Register Based Nationwide Cohort Study
title_full Clarithromycin in Early Pregnancy and the Risk of Miscarriage and Malformation: A Register Based Nationwide Cohort Study
title_fullStr Clarithromycin in Early Pregnancy and the Risk of Miscarriage and Malformation: A Register Based Nationwide Cohort Study
title_full_unstemmed Clarithromycin in Early Pregnancy and the Risk of Miscarriage and Malformation: A Register Based Nationwide Cohort Study
title_short Clarithromycin in Early Pregnancy and the Risk of Miscarriage and Malformation: A Register Based Nationwide Cohort Study
title_sort clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534696/
https://www.ncbi.nlm.nih.gov/pubmed/23301061
http://dx.doi.org/10.1371/journal.pone.0053327
work_keys_str_mv AT andersenjontrærup clarithromycininearlypregnancyandtheriskofmiscarriageandmalformationaregisterbasednationwidecohortstudy
AT petersenmorten clarithromycininearlypregnancyandtheriskofmiscarriageandmalformationaregisterbasednationwidecohortstudy
AT jimenezsolemespen clarithromycininearlypregnancyandtheriskofmiscarriageandmalformationaregisterbasednationwidecohortstudy
AT broedbaekkasper clarithromycininearlypregnancyandtheriskofmiscarriageandmalformationaregisterbasednationwidecohortstudy
AT andersennadialyhne clarithromycininearlypregnancyandtheriskofmiscarriageandmalformationaregisterbasednationwidecohortstudy
AT torppedersenchristian clarithromycininearlypregnancyandtheriskofmiscarriageandmalformationaregisterbasednationwidecohortstudy
AT keidingniels clarithromycininearlypregnancyandtheriskofmiscarriageandmalformationaregisterbasednationwidecohortstudy
AT poulsenhenrikenghusen clarithromycininearlypregnancyandtheriskofmiscarriageandmalformationaregisterbasednationwidecohortstudy